T76690
Mavrilimumab
TargetMol
DESCRIPTION
Mavrilimumab (CAM 3001) is a monoclonal antibody with antiviral activity that targets the α subunit of the granulocytic-macrophage colony-stimulating factor (GM-CSF) receptor, inhibiting downstream intracellular GM-CSF signaling. GM-CSF may contribute to an overactive inflammatory response linked to respiratory failure and death and could be used to study rheumatoid arthritis.
DETAILS
- Cas: 1085337-57-0
- Purity: SDS-PAGE:95% SEC-HPLC:95%
- Category: Compound
Lead Time: < 1 week
Sign in to view pricingEquivalent Items
| ... Loading